The information given in the article is short on detail and long on optimism. It sounds similar if not the same as Lu177 being administered which binds to PSMA. One of our members investigated this and was due to have it abroad. This is extremely expensive. Because of this it is a prerequiste that a man has suitable PSMA (about 10% of men don't). This takes the form of a 68 Gallium PSMA scan. There are very few hospitals in the UK presently doing this scan and a man would be very lucky indeed to have it on the NHS. The cost varies between about £2,200 and over £3,000 in the UK depending on the hospital for this scan privately. The centre where I had this done were charging £2,400.and this was for diagnosis reasons in my case. Replacing the Gallium 68 with Lu177 as a way of treatment would be many times more expensive than this over several sessions.. There is also is similar treatment using a another ligand.
There is a thread I started here which may be of interest. https://community.prostatecanceruk.org/posts/t13262-Lutetium-177---PSMA-Treatment
Should anybody find more about this or if what the recent Express article involves in more detail, please post. We are always interested in advances that are taking place.
Edited by member 25 Jun 2018 at 18:05
| Reason: Not specified